Company intelligence / Profile preview

BodyFast

Ownership: Private
Development stage: Commercial

Overview

BodyFast is an active digital health company offering an app-based solution for intermittent fasting. The app provides personalized fasting plans and coaching to help users lose weight and improve overall well-being. It does not develop drugs or medical devices but leverages evidence-based approaches to support healthy habits through guided fasting programs[1][2].

Therapeutic areas: OtherEndocrinology
Modalities: Non-pharmacological therapyDigital health intervention (app-based intermittent fasting coaching)
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on BodyFast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BodyFast.

Explore the full profile